Clinical Trial Update: Intracoronary Administration of Glucocorticoids as a Treatment Method for No-Glucocorticoid Treatment for No-Reflow in STEMI [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intracoronary glucocorticoids for no-reflow in STEMI has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ischemia-reperfusion Injury
• No-reflow

Drugs mentioned

• glucocorticoids (glucocorticoids)

Snippet

Sponsor: Amosov National Institute of Cardiovascular Surgery | Conditions: Ischemia-reperfusion Injury, No-reflow | Phase 2 | Status: COMPLETED